In a blinding-swift reaction to reports of a single monkeypox case in the U.S., President Biden has ordered $119 million of a vaccine for it, from Bavarian Nordic — a company that already has a contract for it under the name “Jynneos.”
“Under the contract, the Biden administration has the option to place another order worth $180 million. That would allow for about 13 million freeze-dried doses of the Jynneos smallpox vaccine to be manufactured by around 2024 and 2025. The majority of the bulk vaccine for those doses has already been manufactured and invoiced, according to the company,” The Epoch Times reported.
The FDA approved the vaccine in September 2019 to prevent both smallpox and monkeypox. The reasoning at that time was that health officials feared an ‘intentional release” of smallpox at some future point.
SOURCE:
The Epoch Times May 20, 2022